Clinical trial
Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced…
NCT00201747 · Ohio State University Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00201747 |
|---|---|
| Title | Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach Cancer |
| Official title | Phase II Randomized Trial of Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach Cancer |
| Lead sponsor | Ohio State University Comprehensive Cancer Center, Other |
| Collaborators | Pharmacia and Upjohn Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Esophageal Cancer, Esophagus Cancer, Cancer of Stomach, Stomach Cancer |
| Intervention type | Drug |
| Interventions | CPT-11, Mitomycin C |
| Enrollment | 80 |
| Start date | Sep 1, 2001 |
| Primary completion | Oct 1, 2006 |
| Completion | Feb 1, 2010 |
| First posted | Sep 20, 2005 |
| Last update posted | Dec 6, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: